Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus

NATerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Barrett's EsophagusEsophageal Neoplasms
Interventions
DEVICE

Radiofrequency Ablation(RFA) by HALO device.

RFA or Surveillance every 2 months for 1 year.

DEVICE

Endoscopic mucosal resection(EMR) by mucosectomy kit.

EMR or surveillance every 2 months.

Trial Locations (3)

10032

Columbia University, New York

60637

University Of Chicago, Chicago

63141

Barnes-Jewish Hospital, St Louis

All Listed Sponsors
collaborator

American Society for Gastrointestinal Endoscopy

OTHER

collaborator

Cook Group Incorporated

INDUSTRY

collaborator

Washington University School of Medicine

OTHER

collaborator

Columbia University

OTHER

collaborator

University of Chicago

OTHER

lead

Midwest Biomedical Research Foundation

OTHER

NCT01572987 - Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus | Biotech Hunter | Biotech Hunter